Experimental Vaccine to Prevent Fentanyl Overdose Enters Human Trials
An experimental “anti-fentanyl” vaccine developed by ARMR Sciences, Inc. of New York and the University of Houston has entered Phase 1/2 human trials, according to a June 17 press release issued by the company. The vaccine candidate has spent years in development and vaccine developers say it represents a potential intervention in America’s ongoing overdose […]
AI Designed a Universal Coronavirus Vaccine for Viruses Not Yet in Existence
University of Cambridge researchers have developed what they describe as a “fundamentally new” type of vaccine designed exclusively using artificial intelligence (AI), marking the first time a vaccine’s active antigen was created entirely through computational modeling and tested in humans. The vaccine candidate, pEVAC-PS, was developed by DIOSynVax Ltd., a biotechnology company founded out of […]
Pfizer/Valneva Aim for FDA Approval of mRNA Shot for Lyme Disease
On Mar. 23, 2026, Pfizer, Inc. of New York City, NY and Valneva SE of Saint-Herblain, France announced that they would seek regulatory approval from the U.S. Food and Drug Administration (FDA) for an experimental mRNA (messenger ribonucleic acid) biologic shot against Lyme disease that they have jointly been developing since 2020. The shot, designated […]
FDA Greenlights Review of Moderna’s mRNA Flu Shot After Application Amended
On Feb. 18, 2026, the U.S. Food and Drug Administration (FDA) agreed to review Moderna’s application for its mRNA influenza shot, known as mRNA-1010, after the company amended its submission to address regulatory concerns. The agency accepted the updated biologics license application and set a target action date of Aug. 5, 2026, allowing the shot […]
U.S. Researcher Wins $1.9 Million USDA Grant to Develop Novel Bird Flu Vaccine
The U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) has awarded a three-year, $1.9 million grant to a researcher at the University of Missouri School of Medicine and the College of Veterinary Medicine to develop a novel vaccine against highly pathogenic avian influenza (HPAI) (“bird flu”) and Newcastle disease—another fatal, viral […]
Nipah Virus Cases in Asia Increase Pressure to Develop a Vaccine
On Jan. 26, 2026, the government of India confirmed two cases of Nipah virus (NiV) infection in its state of West Bengal. Both cases involved health care workers in a hospital in the district of North 24 Parganas. One of the individuals died after being hospitalized on Jan. 28. Contact tracing linked a total of […]